Skip to content

Michael Burry’s largest stock position surged 25% in a week

Michael Burry’s largest stock position surged 25% in a week

In the stock market, nothing speaks louder than numbers, and this week the traveling sector is almost deafening.

Expedia Group Inc. (NASDAQ: EXPE), the prized largest position of Michael Burry’s investment portfolio, has soared an additional 10% on November 7, according to a report by Michael Burry Stock Tracker account on X (Twitter). Remarkably, this move totaled a 25% increase over the past week.

Notably, Michael Burry, known for his lucrative ‘Big Short’ against the housing market in 2008, featured in a movie called “The Big Short” in 2015.

At the time of publication, EXPE is trading at $118.05 per share, with 5.79% gains in the last 24 hours.

EXPE 1-week price chart. Source: Finbold

Expedia fundamental analysis and Michael Burry’s positioning

The ascent of Expedia’s shares is attributed to a bullish announcement from the company: a colossal $5 billion stock buyback plan coupled with the report of record revenues. 

This tailwind comes just in time as Expedia has recently been spotlighted as a new addition to Burry’s holdings in his Q2 filings revealed to the public.

Interestingly, this company’s performance and fundamental analysis are a strong indicator of the resilience of the travel industry, even in the face of relentless inflation and economic uncertainty.

In its latest report, Expedia Group Inc. witnessed a revenue upswing of 9% to $3.93 billion. Gross bookings were not far behind, ascending 7% to reach $25.7 billion. As for EBITDA, it showed robust growth of 1.1% year-over-year, translating into a 31% expansion.

Since Michael Burry’s positioning on August 14th, EXPE stocks have impressively climbed more than 5%, reflecting investors’ renewed confidence in the travel industry and in Burry’s strategic investment choices.

EXPE daily chart on Nasdaq. Source: TradingView

Market enthusiasts and followers of Burry’s famed investing acumen are now eagerly awaiting his upcoming filing. The anticipated document will shed light on any recent adjustments the investor might have made to his stock exposures after the observed volatility.

Expedia’s performance is a beacon for the travel sector, projecting a relentless march forward despite the cost-of-living crunch. In the coming days, all eyes will be on one of the most famous traders in the world’s next move and whether he will continue to bank on the travel industry’s robust momentum.

Buy stocks now with Interactive Brokers – the most advanced investment platform


Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.